Side-by-side comparison of AI visibility scores, market position, and capabilities
AP automation and spend management platform with AI-driven invoice processing for mid-market and enterprise. Stockholm SE, private equity backed.
Medius is an accounts payable automation and spend management company that provides AI-powered invoice processing, approval workflow, and spend analytics for mid-market and enterprise organizations. Headquartered in Stockholm, Sweden, Medius is backed by private equity and has grown through organic development and acquisitions to serve customers across North America, Europe, and Australia. The company's platform applies machine learning to automate invoice capture, data extraction, coding, and matching, with the stated goal of enabling touchless invoice processing — handling invoices from receipt to payment without human intervention — at rates that reduce AP team workload significantly.\n\nMedius's platform covers the full source-to-pay lifecycle including supplier management, purchase order management, three-way matching, invoice workflow, and payment, with spend analytics dashboards that give procurement and finance leaders visibility into total spend by supplier, category, cost center, and geography. The platform's AI learns continuously from an organization's approval patterns and coding history to improve automation rates over time, typically achieving touchless processing rates of 80 percent or higher at mature customer deployments. Medius integrates with major ERP systems including SAP, Microsoft Dynamics, Infor, and IFS.\n\nMedius has a particularly strong market position in the Scandinavian and broader European enterprise market, where it competes with Basware, Tradeshift, and Coupa, as well as with North American AP automation vendors including Tipalti and Stampli. Its focus on high automation rates, deep ERP integration, and the full source-to-pay scope differentiates it from point-solution AP tools and positions it as a serious enterprise competitor in the European and global market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.